Target enrollment is complete for a Phase 1b trial testing the safety and tolerability of GT-02287 in people with Parkinson’s disease.| Parkinson's News Today
Living within three miles of a golf course may increase the risk of Parkinson’s disease, possibly due to pesticide exposure, per a study.| Parkinson's News Today
Medical scientists recognize two types of Parkinson's disease: primary parkinsonism and forms known as atypical and secondary parkinsonism.| Parkinson's News Today
Microglia-driven inflammation plays key role in Parkinson’s disease development by contributing to the spread of abnormal clumps, per a study.| Parkinson's News Today
The FDA has cleared CAP-003, a gene therapy for Parkinson’s associated with GBA mutations, to be tested in clinical trials.| Parkinson's News Today
Parkinson's patients in a pilot study at Texas A&M say they enjoy equine-assisted therapy, and researchers hope to prove it's effective.| Parkinson's News Today
Casma Therapeutics will develop CSM-101 as a potential oral treatment for Parkinson's disease and Gaucher disease.| Parkinson's News Today
Cure Parkinson’s is funding SLEIPNIR, a clinical trial platform that will simultaneously test up to three disease-modifying treatments.| Parkinson's News Today
Blood levels of 2 proteins in REM sleep behavior disorder patients linked with later finding of Parkinson's-like disease, Lewy body dementia.| Parkinson's News Today
Poor hand grip strength was tied to a higher risk of developing Parkinson’s in a U.K. study, especially among those with genetic risk factors.| Parkinson's News Today
While there's no test to confirm a Parkinson's diagnosis in its early stages, the disease can be detected based on a variety of symptoms.| Parkinson's News Today
Parkinson's disease symptoms affect both motor skills and nonmotor skills, and progress differently in each person.| Parkinson's News Today
The American Parkinson Disease Association (APDA) has awarded $2.6 million to research projects aiming to better understand Parkinson's.| Parkinson's News Today
The FDA approved a brain mapping tool that will enable doctors to more precisely use neuromodulation therapies like DBS.| Parkinson's News Today
UCF researchers have developed a biosensor that can rapidly detect and quantify dopamine levels in unprocessed blood samples.| Parkinson's News Today
The clinical trial is assessing the safety of Allyx Therapeutics' ALX-001 versus a placebo when given to adults twice daily for 28 days.| Parkinson's News Today
Learn about Parkinson's disease, a condition that affects the brain, resulting in issues with movement, balance, and more.| Parkinson's News Today